Gregory L. Verdine, Director at Wave Life Sciences Ltd. (WVE), sold 56,678 shares at $30.27 ($1.7M) on 2019-11-20, disclosed to the SEC on 2019-11-22.
Open-market sale of $1.7M WVE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.27 | 24,030 | $727K | 42.0% |
| 2 | $30.27 | 24,030 | $727K | 42.0% |
| 3 | $31.59 | 3,400 | $107K | 6.2% |
| 4 | $32.74 | 2,609 | $85K | 4.9% |
| 5 | $32.74 | 2,609 | $85K | 4.9% |
| Total | $30.58 avg | 56,678 |
| $1.7M |
| 100% |
| Filing → |
| WVE | SELL | 2025-06-13 | $209K | — | Filing → |
| WVE | SELL | 2018-11-16 | $996K | — | Filing → |
| WVE | SELL | 2016-06-17 | $868K | — | Filing → |